Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 425
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT00022191 | Cisplatin Plus Gemcitabine With or Without Paclitaxel in Treating Patients With Stage IV Urinary Tract Cancer | ||
| NCT00025636 | Combination Chemotherapy and Peripheral Stem Cell Transplant in Treating Patients With Relapsed Hodgkin's Lymphoma | ||
| NCT01913652 | Ph II Cabazitaxel DD Liposarcoma | ||
| NCT00028691 | Chlorambucil Compared With Radiation Therapy in Treating Patients With Previously Untreated Stage III or Stage IV Follicular Lymphoma | ||
| NCT01788982 | Nintedanib(BIBF1120) in Thyroid Cancer | ||
| NCT00005061 | Monoclonal Antibody Therapy in Treating Patients With Relapsed or Refractory Solid Tumors | ||
| NCT02781935 | Diffusion-Weighted MRI for Liver Metastasis | ||
| NCT00002623 | Chemotherapy Followed by Surgery or Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer | ||
| NCT06407401 | Improvement of Quality of Life Through Supportive Treatments for Hormone Therapy - Related Symptoms in Patients With Early Breast Cancer | ||
| NCT03443856 | Postoperative Immunotherapy vs Standard Chemotherapy for Gastric Cancer With High Risk for Recurrence | ||
| NCT02194842 | Phase III Radium 223 mCRPC-PEACE III | ||
| NCT03818997 | Combination of Targeted and Immunotherapy for Advanced Biliary Tract and Esophagogastric Gastric Cancer | ||
| NCT03482362 | Vinorelbine in Advanced BRAF-like Colon Cancer | ||
| NCT00003062 | Temozolomide in Patients With Progressive or Recurrent Non-small Cell Lung Cancer | ||
| NCT00005062 | Radiation Therapy in Patients With Limited-Stage Small Cell Lung Cancer in Complete Remission | ||
| NCT01723969 | Screening Platform for Clinical Trials in Advanced Colorectal Cancer | ||
| NCT00002719 | Combination Chemotherapy With or Without G-CSF in Treating Older Patients With Acute Myeloid Leukemia | ||
| NCT04065165 | Lanreotide Combined With Telotristat Ethyl or Placebo for the First-line Treatment in Patients With Advanced Well Differentiated Small Intestinal Neuroendocrine Tumours (siNET) With Highly-functioning Carcinoid Syndrome | ||
| NCT02470065 | Neoadjuvant Afatinib in Early Stage Non Small Cell Lung Cancer. | ||
| NCT00182819 | Radiation Therapy or Temozolomide in Treating Patients With Gliomas | ||
| NCT01795521 | LungTech: Stereotactic Body Radiotherapy (SBRT) of Inoperable Centrally Located NSCLC | ||
| NCT00036816 | Vaccine Therapy in Treating Patients With Melanoma of the Eye | ||
| NCT00004885 | Fluorouracil and Leucovorin With or Without Irinotecan in Treating Patients With Metastatic Colorectal Cancer | ||
| NCT01597414 | Elderly Metastatic Breast Cancer: Pertuzumab-Herceptin vs Pertuzumab-Herceptin-Metronomic Chemotherapy, Followed by T-DM1 | ||
| NCT06246149 | Adjuvant Tebentafusp in High Risk Ocular Melanoma | ||
| NCT00766155 | Chemotherapy and Radiation Therapy Before Surgery Followed by Capecitabine With or Without Oxaliplatin in Treating Patients With Locally Advanced Rectal Cancer | ||
| NCT00002555 | High-Dose Radiation Therapy With or Without Chemotherapy in Treating Patients With Head and Neck Cancer | ||
| NCT00526149 | BI 2536 in Treating Patients With Recurrent or Metastatic Solid Tumors | ||
| NCT04031677 | Surgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal Sarcoma | ||
| NCT00003772 | Quality-of-Life Assessment in Patients With Ovarian Cancer | ||
| NCT04402073 | Personalized Risk-Adapted Therapy in Post-Pubertal Patients With Newly-Diagnosed Medulloblastoma | ||
| NCT00003418 | Exemestane Compared With Tamoxifen in Treating Postmenopausal Women With Primary Breast Cancer | ||
| NCT06326190 | 177Lu-DOTATATE for Recurrent Meningioma | ||
| NCT01185886 | Study of Blood and Tissue Samples in Children With Newly Diagnosed Acute Lymphoblastic Leukemia | ||
| NCT00003803 | Chemotherapy Plus Radiation Therapy in Treating Patients With Stage I, Stage II, or Stage III Non-small Cell Lung Cancer That Cannot Be Surgically Removed | ||
| NCT00086879 | Erlotinib Compared With Temozolomide or Carmustine in Treating Patients With Recurrent Glioblastoma Multiforme | ||
| NCT00004884 | Docetaxel and Gemcitabine Compared With Docetaxel and Cisplatin in Treating Patients With Metastatic or Locally Advanced Pancreatic Cancer | ||
| NCT00003640 | Transurethral Resection and Combination Chemotherapy in Treating Patients With Stage II or Stage III Bladder Cancer | ||
| NCT02929394 | Trabectedin Maintenance Post 1st-line in STS | ||
| NCT00002503 | Strontium Compared With Radiation Therapy in Treating Patients With Hormone-Refractory Prostate Cancer With Painful Bone Metastases | ||
| NCT00002700 | Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Acute Lymphoblastic Leukemia | ||
| NCT02273271 | Evaluation of FLT-PET and DWI-MRI in Patients With NSCLC Treated With a Platinum-based Doublet as Preoperative Chemo | ||
| NCT07234877 | Phase II Study of Upfront SRT Plus Ivonescimab/Chemotherapy vs Ivonescimab/Chemotherapy in NSCLC Brain Mets | ||
| NCT00052312 | Doxorubicin and Cisplatin With or Without Paclitaxel in Treating Patients With Locally Advanced, Metastatic, and/or Relapsed Endometrial Cancer | ||
| NCT00002839 | Combination Chemotherapy Plus Radiation Therapy To Preserve the Larynx in Patients With Cancer of the Hypopharynx or Larynx | ||
| NCT00410683 | Radiation Therapy in Treating Patients With Non Small Cell Lung Cancer That Has Been Completely Removed by Surgery | ||
| NCT02580994 | Pembrolizumab in Untreated Extensive SCLC | ||
| NCT00685828 | Imatinib Mesylate in Treating Patients With Unresectable or Metastatic Gastrointestinal Stromal Tumor | ||
| NCT01522612 | Colorectal Cancer (CRC) Cetuximab Elderly Frail | ||
| NCT00263822 | Erlotinib or Observation in Treating Patients Who Have Undergone First-Line Chemotherapy for Ovarian Cancer, Peritoneal Cancer, or Fallopian Tube Cancer |
